A carregar...
Timing is everything in the treatment of multiple sclerosis
We present two similar cases of relapsing–remitting multiple sclerosis, both of whom received treatment with the monoclonal antibody alemtuzumab, but had significantly different long-term outcomes. Patient A is 12 years into his illness and was treated early in his disease course, he has no disabili...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4401937/ https://ncbi.nlm.nih.gov/pubmed/25878229 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-208960 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|